BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Skin cancer AND SMARCB1, Ini1, 6598, ENSG00000099956, Snr1, SNF5L1, RDT, BAF47, hSNFS, SNF5, INI1, Sfh1p, Q12824 AND Treatment
18 results:

  • 1. Schwannomatosis: a Realm Reborn: year one.
    Planet M; Kalamarides M; Peyre M
    Curr Opin Oncol; 2023 Nov; 35(6):550-557. PubMed ID: 37820090
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Primary Epithelioid Sarcoma of the Conchal Bowl in a 64-Year-Old Male: A Case Report and Review of the Literature.
    Li L; Bailiff OA; Blanchard B; Gardner JM
    Am J Dermatopathol; 2023 Jun; 45(6):383-387. PubMed ID: 37191372
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. A rapidly growing cutaneous malignant glomus tumor with a CCND3 mutation.
    Kitz R; Leung O; Royer M
    J Cutan Pathol; 2023 Feb; 50(2):113-117. PubMed ID: 36059094
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. WP1066 induces cell death in a schwannomatosis patient-derived schwannoma cell line.
    Allaf A; Victoria B; Rosario R; Misztal C; Humayun Gultekin S; Dinh CT; Fernandez-Valle C
    Cold Spring Harb Mol Case Stud; 2022 Jun; 8(4):. PubMed ID: 35732500
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. An SS18::NEDD4 cutaneous spindled and epithelioid sarcoma: An hitherto unclassified cutaneous sarcoma, resembling epithelioid sarcoma with aggressive clinical behavior.
    Patton A; Oghumu S; Iwenofu OH
    Genes Chromosomes Cancer; 2022 Oct; 61(10):635-640. PubMed ID: 35639915
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. ERN GENTURIS clinical practice guidelines for the diagnosis, treatment, management and surveillance of people with schwannomatosis.
    Evans DG; Mostaccioli S; Pang D; Fadzil O Connor M; Pittara M; Champollion N; Wolkenstein P; Thomas N; Ferner RE; Kalamarides M; Peyre M; Papi L; Legius E; Becerra JL; King A; Duff C; Stivaros S; Blanco I
    Eur J Hum Genet; 2022 Jul; 30(7):812-817. PubMed ID: 35361920
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. In Vivo Study of the Efficacy and Safety of 5-Aminolevulinic Radiodynamic Therapy for Glioblastoma Fractionated Radiotherapy.
    Takahashi J; Nagasawa S; Doi M; Takahashi M; Narita Y; Yamamoto J; Ikemoto MJ; Iwahashi H
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575921
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Current Understanding of Neurofibromatosis Type 1, 2, and Schwannomatosis.
    Tamura R
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072574
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. skin maculae, chronic diarrhea, cachexia, and splenomegaly-Late presentation of the first autochthonous case of visceral leishmaniasis in Tanzania.
    Henke O; Mapendo PJ; Mremi A; Mmbaga LG; Pallangyo AE; Harbaum T; Mkwizu E
    PLoS Negl Trop Dis; 2021 Jan; 15(1):e0008925. PubMed ID: 33444339
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. What to know about schwannomatosis: a literature review.
    Schraepen C; Donkersloot P; Duyvendak W; Plazier M; Put E; Roosen G; Vanvolsem S; Wissels M; Bamps S
    Br J Neurosurg; 2022 Apr; 36(2):171-174. PubMed ID: 33263426
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Epithelioid Sarcoma of the Peripheral Nerve: Clinicopathologic Series of Three Cases and Literature Review.
    Diaz-Perez JA; Spasic S; Velez-Torres JM; McCarthy EF; Rosenberg AE
    Am J Clin Pathol; 2021 Apr; 155(5):729-737. PubMed ID: 33247294
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. The prognostic role of BRAF and WNT pathways activation in kinase inhibitors-naïve clinical stage III cutaneous melanoma.
    Kowalik A; Jurkowska M; Mierzejewska E; Ługowska I; Gos A; Szumera-Ciećkiewicz A; Zięba S; Koseła-Paterczyk H; van der Oord J; Dębiec-Rychter M; Szamotulska K; Siedlecki J; Rutkowski P
    Melanoma Res; 2020 Aug; 30(4):348-357. PubMed ID: 32073511
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Detection of Germline Mutations of the smarcb1 Gene in a Chinese Family with Intraspinal Schwannomatosis.
    Ding Y; Rong H; Wang Y; Liu T; Zhang J; Li S; Wang Z; Wang Y; Zhu T
    World Neurosurg; 2019 Mar; 123():318-322. PubMed ID: 30576819
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. High-Throughput Functional Genetic and Compound Screens Identify Targets for Senescence Induction in cancer.
    Wang L; Leite de Oliveira R; Wang C; Fernandes Neto JM; Mainardi S; Evers B; Lieftink C; Morris B; Jochems F; Willemsen L; Beijersbergen RL; Bernards R
    Cell Rep; 2017 Oct; 21(3):773-783. PubMed ID: 29045843
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Safe and effective deodorization of malodorous fungating tumors using topical metronidazole 0.75 % gel (GK567): a multicenter, open-label, phase III study (rdt.07.SRE.27013).
    Watanabe K; Shimo A; Tsugawa K; Tokuda Y; Yamauchi H; Miyai E; Takemura K; Ikoma A; Nakamura S
    Support Care Cancer; 2016 Jun; 24(6):2583-90. PubMed ID: 26715293
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Metastatic Malignant Melanoma With Complete Loss of Differentiation Markers (Undifferentiated/Dedifferentiated Melanoma): Analysis of 14 Patients Emphasizing Phenotypic Plasticity and the Value of Molecular Testing as Surrogate Diagnostic Marker.
    Agaimy A; Specht K; Stoehr R; Lorey T; Märkl B; Niedobitek G; Straub M; Hager T; Reis AC; Schilling B; Schneider-Stock R; Hartmann A; Mentzel T
    Am J Surg Pathol; 2016 Feb; 40(2):181-91. PubMed ID: 26448190
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. CTF meeting 2012: Translation of the basic understanding of the biology and genetics of NF1, NF2, and schwannomatosis toward the development of effective therapies.
    Widemann BC; Acosta MT; Ammoun S; Belzberg AJ; Bernards A; Blakeley J; Bretscher A; Cichowski K; Clapp DW; Dombi E; Evans GD; Ferner R; Fernandez-Valle C; Fisher MJ; Giovannini M; Gutmann DH; Hanemann CO; Hennigan R; Huson S; Ingram D; Kissil J; Korf BR; Legius E; Packer RJ; McClatchey AI; McCormick F; North K; Pehrsson M; Plotkin SR; Ramesh V; Ratner N; Schirmer S; Sherman L; Schorry E; Stevenson D; Stewart DR; Ullrich N; Bakker AC; Morrison H
    Am J Med Genet A; 2014 Mar; 164A(3):563-78. PubMed ID: 24443315
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Sorafenib in advanced melanoma: a Phase II randomised discontinuation trial analysis.
    Eisen T; Ahmad T; Flaherty KT; Gore M; Kaye S; Marais R; Gibbens I; Hackett S; James M; Schuchter LM; Nathanson KL; Xia C; Simantov R; Schwartz B; Poulin-Costello M; O'Dwyer PJ; Ratain MJ
    Br J Cancer; 2006 Sep; 95(5):581-6. PubMed ID: 16880785
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.